WallStSmart

Kulicke and Soffa Industries Inc (KLIC)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kulicke and Soffa Industries Inc generates 166% more annual revenue ($687.58M vs $258.90M). KLIC leads profitability with a -9.4% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

KLIC

Avoid

34

out of 100

Grade: F

Growth: 4.0Profit: 3.5Value: 4.7Quality: 7.8
Piotroski: 5/9Altman Z: 4.69

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for KLIC.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KLIC2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.6910/10

Safe zone — low bankruptcy risk

Revenue GrowthGrowth
20.2%8/10

Revenue surging 20.2% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

KLIC4 concerns · Avg: 2.5/10
PEG RatioValuation
2.384/10

Expensive relative to growth rate

Return on EquityProfitability
-7.2%2/10

ROE of -7.2% — below average capital efficiency

EPS GrowthGrowth
-78.8%2/10

Earnings declined 78.8%

Free Cash FlowQuality
$-11.61M2/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : KLIC

The strongest argument for KLIC centers on Altman Z-Score, Revenue Growth. Revenue growth of 20.2% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : KLIC

The primary concerns for KLIC are PEG Ratio, Return on Equity, EPS Growth.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

KLIC profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SEMICONDUCTOR EQUIPMENT & MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 34/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kulicke and Soffa Industries Inc

TECHNOLOGY · SEMICONDUCTOR EQUIPMENT & MATERIALS · USA

Kulicke and Soffa Industries, Inc. designs, manufactures and sells capital equipment and tools for assembling semiconductor devices. The company is headquartered in Singapore.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?